![Pablo D. T. Valenzuela](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pablo D. T. Valenzuela
Fondatore presso Ventria Bioscience, Inc.
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Ahmed Hamdy | M | 59 |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.
Andes Biotechnologies Global, Inc.
![]() Andes Biotechnologies Global, Inc. BiotechnologyHealth Technology Andes Biotechnologies Global, Inc. provides healthcare services. The company was founded in 2017 and is headquartered in Burlingame, CA. | 8 anni |
Luis O. Burzio | M | - |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | 16 anni |
Thomas N. Urban | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
William J. Rutter | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | 31 anni |
Cristian Hernández-Cuevas | M | - |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
Leonardo Marraffini | M | - |
Keclon SA
![]() Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | - |
Patricio Cáceres | M | - |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
Alexander Seelenberger Farba | M | 45 |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile.
Algenis SpA
![]() Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | 15 anni |
Gonzalo Miranda | M | - |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
Lisandro Bril | M | - |
Keclon SA
![]() Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | - |
Margaret B. Glick | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | 11 anni |
Constanza Sigala | F | - |
Algenis SpA
![]() Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | - |
Enrique Hasbún | M | - |
Algenis SpA
![]() Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | - |
Gonzalo Santillan | M | - |
Keclon SA
![]() Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | - |
Agustín Otero Monsegur | M | - |
Keclon SA
![]() Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | - |
Milton Hahn | M | - |
Keclon SA
![]() Keclon SA BiotechnologyHealth Technology Keclon SA engages in the development and generation of synthetic enzymes. Its technology platform allows to rapidly generating new and improved enzymes that can significantly reduce production costs using genetic engineering, synthetic biology and directed evolution tools. The company was founded by Hugo Menzella, Leandro Vetcher, Sebastian Bernales and Salvador Peiru, Rodolfo Cabrera in December 2011, and is headquartered in Rosario, Argentina. | - |
María Teresa Ruiz | F | - |
Chilean Academy of Science
| - |
Patrick Smith | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Deshui Zhang | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Steve C. Pettit | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Bernardita Méndez Velasco | M | - |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
William H. Rutter | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Jorge Selume Zaror | M | 73 |
Algenis SpA
![]() Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | - |
Randy J. Semadeni | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Greg A. Unruh | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Ning Huang | M | - |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Seymour H. Fein | M | 75 |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | 9 anni |
William W. Crouse | M | 80 |
Ventria Bioscience, Inc.
![]() Ventria Bioscience, Inc. BiotechnologyHealth Technology Ventria Bioscience, Inc. operates as a biopharmaceutical company. It offers Express Tec., a plant based recombinant protein supplement. The firm also offers controlling zoonotic disease and also provides access to its platform technology through contract manufacturing services. The company was founded by Raymond L. Rodriguez, Peter Matlock and William J. Rutter in 1993 and is headquartered in Fort Collins, CO. | - |
Catalina del Río | M | - |
Algenis SpA
![]() Algenis SpA BiotechnologyHealth Technology Algenis SpA conducts research on small molecules derived from microalgae. It produces, formulation and clinical developments bioactive molecules produced by marine microalgae with medical application as muscle relaxant and analgesic, as well as for the treatment of neurological diseases. The company also conducted academic clinical research and published their work in several peer-reviewed journals. Algenis was founded in 2002 and is headquartered in Santiago, Chile. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Arturo Yudelevich | M | - |
Andes Biotechnologies SA
![]() Andes Biotechnologies SA BiotechnologyHealth Technology Andes Biotechnologies SA researches and develops effective treatments against cancer. It has developed a new proprietary technology based on the discovery of a novel family of RNA targets of mitochondrial origin that when disrupted by anti-sense technology they selectively destroy cancer cells. The company was founded by Luis O. Burzio, Arturo Yudelevich and Pablo D.T. Valenzuela in 2008 and is headquartered in Santiago, Chile. | - |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Cile | 13 | 43.33% |
Stati Uniti | 13 | 43.33% |
Argentina | 5 | 16.67% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Pablo D. T. Valenzuela
- Contatti personali